News Room
China Or Not, Here Comes Nvidia (NASDAQ:NVDA)
I always find it suspicious when a company is on a complete tear and some piece of the narrative is…
Arcutis Biotherapeutics Shares Jump After FDA OKs Skin-Condition Treatment
By Ben Glickman Shares of Arcutis Biotherapeutics rose late Friday after the company's treatment for a skin condition was approved…
Inside the ‘Gaza metro’: Israel displays Hamas tunnel big enough for a car
At first the tunnel sloped gently downhill, and there was enough natural light to see the concrete-reinforced walls, dodge the…
Minerva Surgical to Delist Stock from Nasdaq
By Sabela Ojea Shares of Minerva Surgical on Friday dropped 55% to $1.27 in after-hours trading after the company said…
The economic year ahead will not be binary
Stay informed with free updatesSimply sign up to the Global Economy myFT Digest -- delivered directly to your inbox.We tend…
Lockheed Martin Gets $663.1M Navy Contract Modification
By Ben Glickman Lockheed Martin was awarded a $663.1 million modification to its contract with the U.S. Navy. The contract…
UK, Germany and France urge Israel to agree ‘sustainable ceasefire’ in Gaza
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Israel faced…
Stocks to Watch: Arcutis Biotherapeutics, Minerva Surgical, Enzo Biochem
By Ben Glickman Arcutis Biotherapeutics received FDA approval for its Zoryve topical foam in the treatment of seborrheic dermatitis late…